Low methylation of SFRP1 (high expression of SFRP1) showed a trend of correlation with better prognosis in patients with pancreatic adenocarcinoma and cholangiocarcinoma (Fig. 4O,T). This evidence concerns the gene SFRP1 and pancreatic adenocarcinoma.